mpeg-r-crisantaspase
Recombinant proteinexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT01551524)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- AsparagineDEGRADER
Asparagine degrader
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- mpeg-r-crisantaspase
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01551524 | Phase 1 | Mar 1, 2012 | EUSA, Jazz Pharmaceuticals, The Lymphoma Academic Research Organisation, University of Lyon |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| EUSA | For profit | 1 | 0 | 1 | 2012 |
| Jazz Pharmaceuticals | For profit | 1 | 1 | 1 | 2012 |
| The Lymphoma Academic Research Organisation | Academic/Hospital | 1 | 0 | 1 | 2012 |
| University of Lyon | Academic/Hospital | 1 | 0 | 1 | 2012 |
4 organizations
Page 1 / 1